BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35242816)

  • 1. Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats.
    Fernández-Quintero ML; Quoika PK; Wedl FS; Seidler CA; Kroell KB; Loeffler JR; Pomarici ND; Hoerschinger VJ; Bujotzek A; Georges G; Kettenberger H; Liedl KR
    Front Mol Biosci; 2022; 9():864654. PubMed ID: 35242816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats.
    Fernández-Quintero ML; Quoika PK; Wedl FS; Seidler CA; Kroell KB; Loeffler JR; Pomarici ND; Hoerschinger VJ; Bujotzek A; Georges G; Kettenberger H; Liedl KR
    Front Mol Biosci; 2022; 9():812750. PubMed ID: 35155578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific antibody derivatives based on full-length IgG formats.
    Grote M; Haas AK; Klein C; Schaefer W; Brinkmann U
    Methods Mol Biol; 2012; 901():247-63. PubMed ID: 22723106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Understanding Thermostability Factors of Barley Limit Dextrinase by Molecular Dynamics Simulations.
    Du J; Dong J; Du S; Zhang K; Yu J; Hu S; Yin H
    Front Mol Biosci; 2020; 7():123. PubMed ID: 32733915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface.
    Lewis SM; Wu X; Pustilnik A; Sereno A; Huang F; Rick HL; Guntas G; Leaver-Fay A; Smith EM; Ho C; Hansen-Estruch C; Chamberlain AK; Truhlar SM; Conner EM; Atwell S; Kuhlman B; Demarest SJ
    Nat Biotechnol; 2014 Feb; 32(2):191-8. PubMed ID: 24463572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Modeling DNA Opening in the Eukaryotic Transcription Initiation Complexes
    Shino G; Takada S
    Front Mol Biosci; 2021; 8():817343. PubMed ID: 34950705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative molecular formats and therapeutic applications for bispecific antibodies.
    Spiess C; Zhai Q; Carter PJ
    Mol Immunol; 2015 Oct; 67(2 Pt A):95-106. PubMed ID: 25637431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Higher Affinity Antibodies Bind With Lower Hydration and Flexibility in Large Scale Simulations.
    Wong MTY; Kelm S; Liu X; Taylor RD; Baker T; Essex JW
    Front Immunol; 2022; 13():969176. PubMed ID: 35860259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
    Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
    MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Identification and Characterization of Thermostable Y-Family DNA Polymerases η, ι, κ and Rev1 From a Lower Eukaryote,
    Vaisman A; McDonald JP; Smith MR; Aspelund SL; Evans TC; Woodgate R
    Front Mol Biosci; 2021; 8():819157. PubMed ID: 34977160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations.
    Shim H
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.
    Zhang X; He X; Li Y; Xu Y; Chen W; Liu X; Hu X; Xiong L; Xu X
    Front Mol Biosci; 2021; 8():826905. PubMed ID: 35004862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Production of Bispecific Antibodies.
    Wang Q; Chen Y; Park J; Liu X; Hu Y; Wang T; McFarland K; Betenbaugh MJ
    Antibodies (Basel); 2019 Aug; 8(3):. PubMed ID: 31544849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy.
    Thomas RG; Surendran SP; Jeong YY
    Front Mol Biosci; 2021; 8():693909. PubMed ID: 34026853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Targeting the N-terminus domain of the coronavirus nucleocapsid protein induces abnormal oligomerization
    Hsu JN; Chen JS; Lin SM; Hong JY; Chen YJ; Jeng US; Luo SY; Hou MH
    Front Mol Biosci; 2022; 9():1036858. PubMed ID: 36299298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Injecting Immunosuppressive M2 Macrophages Alleviates the Symptoms of Periodontitis in Mice.
    Miao Y; He L; Qi X; Lin X
    Front Mol Biosci; 2022; 9():848875. PubMed ID: 35146000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New structural formats of therapeutic antibodies for rheumatology.
    Dumet C; Pottier J; Gouilleux V; Watier H
    Joint Bone Spine; 2018 Jan; 85(1):47-52. PubMed ID: 28461199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting.
    Wen D; Gao Y; Ho C; Yu L; Zhang Y; Lyu G; Hu D; Li Q; Zhang Y
    Front Mol Biosci; 2022; 9():894660. PubMed ID: 35573723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to 'Comparing the effectiveness of training course formats for point-of-care ultrasound in the third trimester of pregnancy'.
    Australas J Ultrasound Med; 2023 Feb; 26(1):69. PubMed ID: 36960134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation.
    Liu S; Yang J; Sun G; Zhang Y; Cheng C; Xu J; Yen K; Lu T
    Front Mol Biosci; 2022; 9():834509. PubMed ID: 35254346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.